Journals Library


EME - 12/10/19

IMPRESS-AF: IMproved exercise tolerance in heart failure with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation

Project title: IMPRESS-AF: IMproved exercise tolerance in heart failure with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation

Call to action: 12/10 12/10 EME Researcher Led Fulls

Research type: Primary Research

Chief investigator: Professor Gregory LipORCID logo

Lead Author: Professor Gregory LipORCID logo

Contractor: University of Birmingham

Cost: £779,084.00

Co-investigators: Dr Abul Mostafa, Dr Eduard ShantsilaORCID logo, Dr James Fisher, Mr Roger Holder, Professor Melanie CalvertORCID logo, Professor Paramjit GillORCID logo, Professor Paulus KirchhofORCID logo.

Started: October 2014 | Status: Published July 2020

ISRCTN: 10259346

Treatment with spironolactone, compared with placebo, did not improve exercise tolerance at 2 years for people experiencing atrial fibrillation and preserved ejection fraction.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.